Analysis
Two separate juries put more than $200 billion in potential Big Tech liability on the table this week, and neither verdict came out of Washington.
A Santa Fe jury found Facebook liable for over 43 million violations of New Mexico's consumer-protection law tied to the 2018 Cambridge Analytica breach, exposing Meta to a statutory ceiling north of $200 billion once a judge sets the actual penalty. Days earlier, a San Diego jury hit Apple with a $5.7 billion verdict for infringing Taction Technology's haptic-feedback patents used in every iPhone and Apple Watch sold since 2015.
Add them up and it's more than $206 billion in fresh legal exposure disclosed in a single week, against two of the largest companies by market cap, from two separate juries in two separate states, over two completely unrelated causes of action.
“What the combined number overstates: neither figure is a check anyone is cutting soon.”
What the combined number overstates: neither figure is a check anyone is cutting soon. Meta's $200 billion is a statutory ceiling -- violations multiplied by the maximum per-violation fine -- that a judge still has to actually impose, and Meta says it will appeal. Apple's $5.7 billion carries no willfulness finding, which caps damages exposure and gives Apple a cleaner appellate path; large patent verdicts are also routinely cut on appeal, the way earlier billion-dollar-range verdicts against Apple eventually were.
What the combined number understates: this is the second time in three months Pulse has tracked a platform or hardware giant absorbing a nine-figure-plus jury verdict outside the antitrust and AI-regulation fights everyone is already watching. State consumer-protection statutes and component-patent juries are a genuinely separate exposure channel from the FTC and DOJ cases GPs are used to pricing, and per-violation math scales in ways flat statutory fines don't.
The diligence shift this implies: any fund with exposure to platform-scale consumer-data companies, or hardware makers shipping patented components at volume, should be tracking state-court jury verdicts as their own line item -- not folding them into the same regulatory-risk bucket as a federal antitrust suit, which moves on a completely different clock and calculus.